|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Domestic sales | |||||
| International sales | |||||
| Total sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Restructuring charges | |||||
| Transaction costs | |||||
| Contingent consideration benefit | |||||
| Impairment of goodwill and indefinite-lived intangible assets | |||||
| Legal costs and regulatory matter expenses | |||||
| Impairment of goodwill | |||||
| Impairment of indefinite-lived intangible assets | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense) | |||||
| Interest income, net | |||||
| Other, net | |||||
| Total other income (expense), net | |||||
| Loss before income tax | |||||
| Income tax (benefit) expense | |||||
| Loss from continuing operations | |||||
| Discontinued operations, net of tax | |||||
| Net loss | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Foreign currency translation adjustment | |||||
| Unrealized (loss) gain on hedging activities | |||||
| Other comprehensive income (loss) | |||||
| Comprehensive loss | |||||
| Loss from continuing operations per share: | |||||
| Basic | |||||
| Diluted | |||||
| Net loss per share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares outstanding: | |||||
| Basic | |||||
| Diluted | |||||
Loading...